Intervet/Schering-Plough Animal Health
Intervet/Schering-Plough Animal Health is the world’s largest developer and marketer of pharmaceuticals and vaccines for aquaculture.
In the United States, the company is best known for developing AQUAFLOR® (florfenicol)i , the first new in-feed antibiotic for U.S. aquaculture in more than 20 years. The broad-spectrum antibiotic is currently approved for control of catfish mortality due to enteric septicemia (ESC) associated with Edwardsiella ictaluri. It is also the only antibiotic approved for controlling mortality in freshwater-reared salmonids due to Flavobacterium psychrophilum (coldwater disease) and furunculosis associated with Aeromonas salmonicida.
In 2007, AQUAFLOR®-CA1 (florfenicol) , became the first and only in-feed antibiotic conditionally approved for the control of mortality in catfish due to columnaris disease associated with Flavobacterium columnare.
Intervet/Schering-Plough Animal Health also offers two immersion vaccines — AQUAVAC-ESC®, for the prevention of ESC disease due to E. ictaluri infection, and AQUAVAC-COL®, licensed as an aid in the prevention of columnaris disease in catfish due to F. columnare infection. Together with AQUAFLOR, the two vaccines offer catfish producers a full range of products for managing ESC and columnaris, the most prevalent and economically significant diseases facing the U.S. catfish industry.
In addition, Intervet/Schering-Plough Animal Health offers CHORULON® (chorionic gonadotropin), an aid in improving spawning function in male and female brood fish.
For more information about Intervet/Schering-Plough Animal Health and its products for aquaculture, call 800-521-5767 or contact your field representative, Kasha Cox, at 662-907-0692.
i - CAUTION: Federal law limits this drug to use under the professional supervision of a licensed veterinarian. Animal feed bearing or containing this veterinary feed directive drug shall be fed to animals only by or upon a lawful Veterinary Feed Directive (VFD) issued by a licensed veterinarian in the course of the veterinarian's professional practice.
ii - AQUAFLOR-CA1 is conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-259.